$BPRN
Princeton Bancorp, Inc.

2023 Q1 Form 10-K Financial Statement

#000119312523079231 Filed on March 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $20.61M $74.08M
YoY Change 20.69% 6.94%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $1.300M $4.488M
YoY Change 25.6% 26.0%
% of Gross Profit
Depreciation & Amortization $441.0K $496.0K $2.052M
YoY Change -6.57% -1.0% 5.18%
% of Gross Profit
Operating Expenses $1.300M $4.488M
YoY Change 25.6% 26.0%
Operating Profit
YoY Change
Interest Expense $3.951M $6.000M
YoY Change 222.79% -10.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $7.998M $9.372M $34.05M
YoY Change 4.8% 14.24% 16.66%
Income Tax $1.901M $2.201M $7.559M
% Of Pretax Income 23.77% 23.48% 22.2%
Net Earnings $6.097M $7.171M $26.49M
YoY Change 1.26% 15.98% 17.82%
Net Earnings / Revenue 29.58% 35.76%
Basic Earnings Per Share $0.97 $4.19
Diluted Earnings Per Share $0.95 $1.126M $4.108M
COMMON SHARES
Basic Shares Outstanding 6.257M 6.320M
Diluted Shares Outstanding 6.386K 6.449K

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $18.02M $53.35M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.66M $11.72M $27.75M
YoY Change -61.1% -61.58% -9.06%
Goodwill $8.853M $8.853M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $2.061M
YoY Change
Other Assets $7.784M $7.599M $7.599M
YoY Change 27.56% 68.34% 68.34%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.585B $1.602B $1.602B
YoY Change -5.52% -5.09% -5.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.160M $1.027M $1.027M
YoY Change 221.91% -1.63% -1.63%
Accrued Expenses $16.47M $16.77M $16.77M
YoY Change -9.13% -9.64% -9.64%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.63M $17.80M $17.80M
YoY Change -0.88% -9.21% -9.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.821M $24.45M $24.45M
YoY Change 10.27% 356.46% 356.46%
Total Long-Term Liabilities $4.821M $24.45M $24.45M
YoY Change 10.27% 356.46% 356.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.63M $17.80M $17.80M
Total Long-Term Liabilities $4.821M $24.45M $24.45M
Total Liabilities $1.360B $1.382B $1.382B
YoY Change -7.15% -6.04% -6.04%
SHAREHOLDERS EQUITY
Retained Earnings $135.4M $131.5M
YoY Change 17.98%
Common Stock $96.88M $115.8M
YoY Change 1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $225.3M $219.6M $219.6M
YoY Change
Total Liabilities & Shareholders Equity $1.585B $1.602B $1.602B
YoY Change -5.52% -5.09% -5.09%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $6.097M $7.171M $26.49M
YoY Change 1.26% 15.98% 17.82%
Depreciation, Depletion And Amortization $441.0K $496.0K $2.052M
YoY Change -6.57% -1.0% 5.18%
Cash From Operating Activities $7.186M $7.627M $23.99M
YoY Change 54.97% 28.12% 85.9%
INVESTING ACTIVITIES
Capital Expenditures $245.0K $66.00K $607.0K
YoY Change -198.0% -109.82% -150.92%
Acquisitions
YoY Change
Other Investing Activities -$19.59M $8.870M -$25.85M
YoY Change -67.09% -718.55% -645.82%
Cash From Investing Activities -$19.84M $8.804M -$26.46M
YoY Change -66.82% -518.04% -846.53%
FINANCING ACTIVITIES
Cash Dividend Paid $1.876M $6.457M
YoY Change 12.47% 47.15%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -22.68M -11.05M -102.9M
YoY Change 137.62% -203.32% -258.69%
NET CHANGE
Cash From Operating Activities 7.186M 7.627M 23.99M
Cash From Investing Activities -19.84M 8.804M -26.46M
Cash From Financing Activities -22.68M -11.05M -102.9M
Net Change In Cash -35.33M 5.386M -105.4M
YoY Change -45.39% -62.95% -229.62%
FREE CASH FLOW
Cash From Operating Activities $7.186M $7.627M $23.99M
Capital Expenditures $245.0K $66.00K $607.0K
Free Cash Flow $6.941M $7.561M $23.38M
YoY Change 42.03% 14.13% 65.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001913971
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41589
CY2022 dei Entity Registrant Name
EntityRegistrantName
PRINCETON BANCORP, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-4268702
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
183 Bayard Lane
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Princeton
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08540
CY2022 dei City Area Code
CityAreaCode
609
CY2022 dei Local Phone Number
LocalPhoneNumber
921-1700
CY2022 dei Security12b Title
Security12bTitle
Common stock, no par value
CY2022 dei Trading Symbol
TradingSymbol
BPRN
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
140200000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6257397
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
12161000
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9409000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
13140000
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
2610000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
28050000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1044000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16772000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18561000
CY2021Q4 us-gaap Federal Funds Sold
FederalFundsSold
146697000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
53351000
CY2021Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
158716000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
83402000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
101158000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
200000
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
225000
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
201000
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
208000
CY2022Q4 bprn Loans Receivable Including Deferred Fees And Cost
LoansReceivableIncludingDeferredFeesAndCost
1370368000
CY2021Q4 bprn Loans Receivable Including Deferred Fees And Cost
LoansReceivableIncludingDeferredFeesAndCost
1335163000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16461000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16620000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1353907000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1318543000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
52617000
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
51479000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11722000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12598000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4756000
CY2021Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4218000
CY2022Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
1742000
CY2021Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
1345000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7599000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4514000
CY2022Q4 us-gaap Goodwill
Goodwill
8853000
CY2021Q4 us-gaap Goodwill
Goodwill
8853000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1825000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2393000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16026000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17914000
CY2022Q4 us-gaap Other Real Estate
OtherRealEstate
0
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
226000
CY2022Q4 us-gaap Other Assets
OtherAssets
5778000
CY2021Q4 us-gaap Other Assets
OtherAssets
5517000
CY2022Q4 us-gaap Assets
Assets
1601779000
CY2021Q4 us-gaap Assets
Assets
1687682000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
265078000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
286247000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1082652000
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1159896000
CY2022Q4 us-gaap Deposits
Deposits
1347730000
CY2021Q4 us-gaap Deposits
Deposits
1446143000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
10000000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1027000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
6649000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
5356000
CY2022Q4 us-gaap Liabilities
Liabilities
1382178000
CY2021Q4 us-gaap Liabilities
Liabilities
1471104000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
5
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
5
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6909402
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6245597
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6820143
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6480355
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
34547000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
34100000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
81291000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80220000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
663805
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
339788
CY2022Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
19452000
CY2021Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10032000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131488000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
111451000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8273000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
839000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
219601000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
216578000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1601779000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1687682000
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
70996000
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
67348000
CY2022 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
986000
CY2021 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
547000
CY2022 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1167000
CY2021 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1172000
CY2022 us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
11000
CY2021 us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
11000
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
923000
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
197000
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
74083000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
69275000
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
5995000
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
6673000
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
5000
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1000
CY2022 us-gaap Interest Expense
InterestExpense
6000000
CY2021 us-gaap Interest Expense
InterestExpense
6674000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
68083000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
62601000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
400000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3625000
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
67683000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
58976000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
2000
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
7000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1138000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1117000
CY2022 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
1852000
CY2021 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
1764000
CY2022 bprn Loan Fees Including Prepayment Penalties
LoanFeesIncludingPrepaymentPenalties
1484000
CY2021 bprn Loan Fees Including Prepayment Penalties
LoanFeesIncludingPrepaymentPenalties
1757000
CY2022 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
386000
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
21000
CY2022 us-gaap Noninterest Income
NoninterestIncome
4862000
CY2021 us-gaap Noninterest Income
NoninterestIncome
4666000
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
20455000
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
17483000
CY2022 us-gaap Occupancy Net
OccupancyNet
5859000
CY2021 us-gaap Occupancy Net
OccupancyNet
6055000
CY2022 us-gaap Professional Fees
ProfessionalFees
2470000
CY2021 us-gaap Professional Fees
ProfessionalFees
2431000
CY2022 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
4488000
CY2021 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
3562000
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
1010000
CY2021 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
792000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
484000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
214000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
239000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
219000
CY2022 us-gaap Other Expense From Real Estate Partnership Operations
OtherExpenseFromRealEstatePartnershipOperations
106000
CY2021 us-gaap Other Expense From Real Estate Partnership Operations
OtherExpenseFromRealEstatePartnershipOperations
241000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
569000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
643000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2812000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2813000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
38492000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
34453000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34053000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29189000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7559000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6703000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.19
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.37
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.11
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.3
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
219601000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
400000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3625000
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1483000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1308000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
44000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.66
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-12723000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1276000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
2000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
7000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-12725000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-1283000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-3613000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-331000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9112000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-952000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17382000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21534000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
2000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
208818000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-952000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22480
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
297000
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
1424
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
33000
CY2021 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4019
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
120000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.66
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
4335000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
339788
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10032000
CY2021 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
2408
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
143000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
216578000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
216578000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9112000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
76900
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1092000
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
8741
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
209000
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
6363000
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
324017
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9420000
CY2022 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3343
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
143000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-49000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-142000
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
5094000
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
9091000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
2000
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
7000
CY2022 bprn Increase In Cash Surrender Value Of Bank Owned Life Insurance
IncreaseInCashSurrenderValueOfBankOwnedLifeInsurance
1138000
CY2021 bprn Increase In Cash Surrender Value Of Bank Owned Life Insurance
IncreaseInCashSurrenderValueOfBankOwnedLifeInsurance
1116000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
527000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
276000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
569000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
643000
CY2022 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-125000
CY2021 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-220000
CY2022 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
101000
CY2021 bprn Stock Based Compensation Directors Compensation
StockBasedCompensationDirectorsCompensation
120000
CY2022 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-942000
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
2549000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-513000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3297000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23987000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12903000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5377000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
41961000
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
6701000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
10338000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3659000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4675000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
8000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
7000
CY2022 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
30444000
CY2021 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-34156000
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
2500000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
607000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1192000
CY2022 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
397000
CY2021 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
-21000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26457000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3544000
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-98413000
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
78877000
CY2022 bprn Proceeds From Overnight Borrowings
ProceedsFromOvernightBorrowings
-10000000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
6457000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
4388000
CY2022 us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
94000
CY2021 us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
53000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9420000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10032000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1092000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
297000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
209000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
33000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-102895000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64840000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-105365000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81287000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158716000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77429000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53351000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158716000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
6017000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
8106000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6985000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9025000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1504000
CY2021 bprn Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
1504000
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2007-03-05
CY2022 us-gaap Year Founded
YearFounded
2007
CY2022 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2007-04-23
CY2007Q2 bprn Number Of Branches Owned By The Entity
NumberOfBranchesOwnedByTheEntity
23
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Estimates </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Because of uncertainties associated with estimating the amounts, timing and likelihood of possible outcomes, actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses and evaluation of the potential impairment of goodwill. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management believes that the allowance for loan losses is adequate as of December 31, 2022 and 2021. While management uses current information to recognize losses on loans, future additions to the allowance for loan losses may be necessary based on changes in economic conditions in the market area or other factors. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, various regulatory agencies, as an integral part of their examination process, periodically review the Bank’s allowance for loan losses. Such agencies may require the Bank to effect certain changes that result in additions to the allowance based on their judgments about information available to them at the time of their examinations. </div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Significant group concentrations of credit risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Most of the Bank’s activities are with customers located within the Mercer County, New Jersey, and surrounding areas as well as the five boroughs of New York City and certain Philadelphia, Pennsylvania metropolitan areas. The Bank does not have any portion of its business dependent on a single or limited number of customers or industries, the loss of which would have a material adverse effect on its business. No substantial portion of loans is concentrated within a single industry or group of related industries, except that a significant majority of commercial loans are secured by real estate. There are numerous risks associated with commercial and consumer lending that could impact the borrowers’ ability to repay on a timely basis. They include but are not limited to: the owner’s business expertise, changes in local, national, and in some cases international economies, competition, governmental regulation, and the general financial stability of the borrowing entity. </div>
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Allowance for credit losses </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The allowance for credit losses consists of the allowance for loan losses and the reserve for unfunded lending commitments. The allowance for loan losses represents management’s estimate of losses inherent in the loan portfolio as of the balance sheet date and is recorded as a reduction to loans. The reserve for unfunded lending commitments represents management’s estimate of losses inherent in its unfunded loan commitments and is recorded in other liabilities on the Consolidated Statements of Financial Condition. The allowance for loan losses is increased by the provision for loan losses and recoveries, and decreased by charge-offs. Loans deemed to be uncollectible are charged against the allowance for loan losses, and subsequent recoveries, if any, are credited to the allowance. All, or part, of the principal balance of loans receivable are charged off to the allowance as soon as it is determined that the repayment of all, or part, of the principal balance is highly unlikely. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The allowance for loan losses is maintained at a level considered adequate to provide for probable losses. The Bank performs, at least quarterly, an evaluation of the adequacy of the allowance. The allowance is based on past loan loss experience (which is bound by the Bank’s limited operating history), known and inherent risks in the portfolio, adverse situations that may affect the borrower’s ability to repay, the estimated value of any underlying collateral, the composition of the loan portfolio, current economic conditions and other relevant factors. This evaluation is inherently subjective as it requires material estimates that may be susceptible to significant revision as more information becomes available. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The allowance consists of specific, general and unallocated components. The specific component relates to loans that are classified as impaired. For loans that are classified as impaired, an allowance is established when the discounted cash flows (or collateral value or observable market price) of the impaired loan is lower than the carrying value of that loan. The general component covers pools of loans by loan segment, including loans not considered impaired, as well as smaller balance homogeneous loans, such as residential mortgage, home equity and consumer loans. These pools of loans are evaluated for loss exposure based upon historical loss rates for each of these loan segments, adjusted for qualitative factors. These qualitative risk factors include: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">1.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Lending policies and procedures, including underwriting standards and collection, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">charge-off,</div> and recovery practices; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">2.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">National, regional, and local economic and business conditions, as well as the condition of various market segments; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">3.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Nature and volume of the portfolio and terms of loans; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">4.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Experience, ability, and depth of lending management and staff; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">5.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Volume and severity of past due, classified and nonaccrual loans, as well as other loan modifications; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">6.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quality of the Bank’s loan review system, and the degree of oversight by the Bank’s board of directors; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">7.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Existence and effect of any concentrations of credit and changes in the level of such concentrations; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">8.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Changes in the value of underlying collateral for collateral-dependent loans; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">9.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Effect of external factors, such as competition and legal and regulatory requirements. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Bank determines the allowance for loan losses by portfolio segment, which consists of commercial real estate loans, commercial and industrial loans, construction loans, residential first-lien mortgage loans, home equity and consumer loans. The Bank estimates the inherent risk of loss on all loans by portfolio segment, based primarily on the risk factors identified above and by applying a weight factor ranging from <span style="-sec-ix-hidden:hidden71676579">4</span> bps (low risk) to 24 bps (severely high risk) to each element for each portfolio segment. The Bank does not apply any qualitative factors to the loans originated from PPP, based on the U.S. governments guarantee and the Coronavirus Aid, Relief and Economic Securities Act (“CARES”) requirement to classify these loans at 0.0% risk weighting asset in determining risk-based capital ratio. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each factor is assigned a value to reflect improving, stable or declining conditions based on management’s best judgment using relevant information available at the time of the evaluation. Adjustments to the factors are supported through documentation of changes in conditions in a narrative accompanying the allowance for loan loss calculation. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Residential first-lien mortgage loans and home equity loans involve certain risks such as interest rate risk and risk of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-repayment.</div> Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying property may be adversely affected by higher interest rates. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Construction lending is generally considered to involve a high degree of risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost, including interest, of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily for projects which are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-sold</div> or leased, and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residences. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Commercial real estate lending entails additional risks as compared with single-family residential real estate lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as economic conditions generally. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Commercial and industrial lending is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In most cases, any repossessed collateral for a defaulted commercial business loan will not provide an adequate source of repayment of the outstanding loan balance. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Consumer loans, including home equity loans, generally have shorter terms and higher interest rates than other lending but generally involve more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Collateral for these type of loans includes either first or second liens on residential properties. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness and personal bankruptcy. In most cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan balance. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">PPP loans have a maturity term ranging from <span style="-sec-ix-hidden:hidden71676570">two</span> to five years, but the borrower can apply for complete or partial forgiveness from the U. S. government after six months. Once the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> term expires, the borrower is required to commence making principle and interest payments until maturity. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An unallocated component of the allowance for loan losses is maintained to cover uncertainties that could affect management’s estimate of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in the underlying assumptions used in the methodologies for estimating specific and general losses in the portfolio. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A loan is considered impaired when, based on current information and events, it is probable that the Bank will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired loans. Management determines the significance of payment delays and payment shortfalls on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">case-by-case</div></div> basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">loan-by-loan</div></div> basis for commercial real estate loans, commercial and industrial loans and construction loans by either the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the loan collateral if the loan is collateral-dependent. An allowance for loan losses is established for an impaired loan if its carrying value exceeds its estimated fair value. The estimated fair values of substantially all of the Bank’s impaired loans are measured based on the estimated fair value of the loan’s collateral, less costs to sell the property. </div> <div style="font-size:6pt; margin-top:0pt; margin-bottom:0pt"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For commercial real estate loans, estimated fair values of the real estate collateral are determined primarily through third-party appraisals. When a real estate-secured loan becomes impaired, a decision is made regarding whether an updated appraisal of the real estate is necessary. This decision is based on various considerations, including the age of the most recent appraisal, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">loan-to-value</div></div> ratio based on the original appraisal and the condition of the property. Appraised values are discounted to arrive at the estimated selling price of the collateral, which is considered to be the estimated fair value. The discounts also include estimated costs to sell the property. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For commercial and industrial loans secured by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-real</div> estate collateral, such as accounts receivable and inventory and equipment, estimated fair values are determined based on the borrower’s financial statements, inventory reports, accounts receivable aging or equipment appraisals or invoices. Indications of value from these sources are generally discounted based on the age of the financial information or the quality of the assets. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Bank does not separately identify individual residential first-lien mortgage loans, home equity loans and consumer loans for impairment, unless such loans are a troubled debt restructuring. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Loans with modified terms are classified as troubled debt restructurings if the Bank grants borrower concessions and it is deemed that those borrowers are experiencing financial difficulty. Concessions granted under a troubled debt restructuring generally involve a temporary reduction in interest rate or an extension of a loan’s stated maturity date. As part of the Bank’s commitment to provide assistance during the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, the Bank agreed to defer either the principal portion or both principal and interest payments for its customers who requested the deferral and were not delinquent prior to the government shut down. For reporting purposes, loans modified under this program were not classified as a troubled debt restructuring. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Nonaccrual troubled debt restructurings are restored to accrual status if principal and interest payments, under the modified terms, are current for six consecutive months after modification and continued repayment is reasonably assured. Loans classified as troubled debt restructurings are designated as impaired. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The allowance calculation methodology includes further segregation of loan segments into risk-rating categories. The borrower’s overall financial condition, repayment sources, guarantors and value of collateral, if appropriate, are evaluated annually for commercial loans or when credit deficiencies arise, such as delinquent loan payments, for commercial and consumer loans. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Credit quality risk ratings include regulatory classifications of special mention, substandard, doubtful and loss. Loans classified special mention have potential weaknesses that deserve management’s close attention. If uncorrected, the potential weaknesses may result in deterioration of the repayment prospects. Loans classified substandard have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They include loans that are inadequately protected by the current sound net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans classified doubtful have all the weaknesses inherent in loans classified substandard with the added characteristic that collection or liquidation in full, on the basis of current conditions and facts, is highly improbable. Loans classified loss are considered uncollectible and are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">charged-off</div> to the allowance for loan losses. Loans not classified are rated pass. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Based on management’s comprehensive analysis of the loan portfolio, management believes the allowance for loan losses is adequate at the reported dates.</div>
CY2022Q4 bprn Actual Percentage Risk On Loans Receivable
ActualPercentageRiskOnLoansReceivable
0
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
207000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
168000
CY2021 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
331000
CY2022 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
331000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6320000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6667000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.19
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.37
CY2022 us-gaap Net Income Loss
NetIncomeLoss
26494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22486000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6320000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6667000
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
129
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
148
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6449
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6814
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.11
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.3
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94997000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
10000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
11605000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
83402000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
100028000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
1803000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
673000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
101158000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
52026000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5235000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
25574000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6370000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
77600000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
11605000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
34663000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
673000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
34663000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
673000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
166
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5200000
CY2022Q4 bprn Debt Securities Available For Sale Unrealized Losses Percentage Of Amortized Cost Basis Less Than Twelve Months
DebtSecuritiesAvailableForSaleUnrealizedLossesPercentageOfAmortizedCostBasisLessThanTwelveMonths
0.0914
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
25
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6400000
CY2022Q4 bprn Debt Securities Available For Sale Unrealized Losses Percentage Of Amortized Cost Basis Twelve Months Or Longer
DebtSecuritiesAvailableForSaleUnrealizedLossesPercentageOfAmortizedCostBasisTwelveMonthsOrLonger
0.199
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2021Q4 bprn Debt Securities Available For Sale Unrealized Losses Percentage Of Amortized Cost Basis
DebtSecuritiesAvailableForSaleUnrealizedLossesPercentageOfAmortizedCostBasis
0.0191
CY2022 bprn Held To Maturity Securities Debt Year Of Maturity
HeldToMaturitySecuritiesDebtYearOfMaturity
P10Y
CY2022 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3700000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
2000
CY2021 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4700000
CY2021 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
7000
CY2022Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
0
CY2021Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
0
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1372824000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1340448000
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Fee Cost
FinancingReceivableUnamortizedLoanFeeCost
-2456000
CY2021Q4 us-gaap Financing Receivable Unamortized Loan Fee Cost
FinancingReceivableUnamortizedLoanFeeCost
-5285000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16461000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16620000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1353907000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1318543000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
266000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1175000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
13444000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
12229000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
12564000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
551000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
248000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
148000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
118000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
155000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
13692000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
12377000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
118000
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
12719000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
551000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
17405000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
13409000
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
10698000
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
686000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
278000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
278000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
196000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
359000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
17683000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
13687000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
196000
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
11057000
CY2021 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
686000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
1364634000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1372824000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
184000
CY2021Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
1336962000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1340448000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
151000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1372824000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1340448000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16620000
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
400000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
857000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
298000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16461000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
118000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
16343000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
12377000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1360447000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1372824000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16027000
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3625000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
3176000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
144000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16620000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
196000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
16424000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
13687000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1326761000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1340448000
CY2021 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
0
CY2022 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
0
CY2022Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
4900000
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
5600000
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
5639000
CY2020Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
6079000
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
515000
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
778000
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
955000
CY2022Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
4861000
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
5639000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17179000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17849000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5457000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5251000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11722000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12598000
CY2022Q4 bprn Demand Non Interest Bearing Checking
DemandNonInterestBearingChecking
265078000
CY2022Q4 bprn Percentage Of Non Interest Bearing Deposit Liabilities
PercentageOfNonInterestBearingDepositLiabilities
0.1967
CY2021Q4 bprn Demand Non Interest Bearing Checking
DemandNonInterestBearingChecking
286247000
CY2021Q4 bprn Percentage Of Non Interest Bearing Deposit Liabilities
PercentageOfNonInterestBearingDepositLiabilities
0.1979
CY2022Q4 bprn Demand Interest Bearing Checking
DemandInterestBearingChecking
269737000
CY2022Q4 bprn Percentage Of Interest Bearing Deposit Liabilities
PercentageOfInterestBearingDepositLiabilities
0.2001
CY2021Q4 bprn Demand Interest Bearing Checking
DemandInterestBearingChecking
259022000
CY2021Q4 bprn Percentage Of Interest Bearing Deposit Liabilities
PercentageOfInterestBearingDepositLiabilities
0.1791
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
190686000
CY2022Q4 bprn Percentage Of Deposits Savings Deposits
PercentageOfDepositsSavingsDeposits
0.1415
CY2021Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
225579000
CY2021Q4 bprn Percentage Of Deposits Savings Deposits
PercentageOfDepositsSavingsDeposits
0.156
CY2022Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
283652000
CY2022Q4 bprn Percentage Of Deposits Money Market Deposits
PercentageOfDepositsMoneyMarketDeposits
0.2105
CY2021Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
373075000
CY2021Q4 bprn Percentage Of Deposits Money Market Deposits
PercentageOfDepositsMoneyMarketDeposits
0.258
CY2022Q4 bprn Time Deposits250000 Or More
TimeDeposits250000OrMore
83410000
CY2022Q4 bprn Percentage Of Time Deposits250000 Or More
PercentageOfTimeDeposits250000OrMore
0.0619
CY2021Q4 bprn Time Deposits250000 Or More
TimeDeposits250000OrMore
33741000
CY2021Q4 bprn Percentage Of Time Deposits250000 Or More
PercentageOfTimeDeposits250000OrMore
0.0233
CY2022Q4 bprn Time Deposits Other
TimeDepositsOther
255167000
CY2022Q4 bprn Percentage Of Time Deposits Other
PercentageOfTimeDepositsOther
0.1893
CY2021Q4 bprn Time Deposits Other
TimeDepositsOther
268479000
CY2021Q4 bprn Percentage Of Time Deposits Other
PercentageOfTimeDepositsOther
0.1857
CY2022Q4 us-gaap Deposits
Deposits
1347730000
CY2022Q4 bprn Percentage Of Deposit Liabilities
PercentageOfDepositLiabilities
1
CY2021Q4 us-gaap Deposits
Deposits
1446143000
CY2021Q4 bprn Percentage Of Deposit Liabilities
PercentageOfDepositLiabilities
1
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
11600000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
23700000
CY2022Q4 bprn Brokers Deposit Liabilities
BrokersDepositLiabilities
107400000
CY2021Q4 bprn Brokers Deposit Liabilities
BrokersDepositLiabilities
108900000
CY2022Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
3700000
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
4600000
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
81000
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
63000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10000000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0461
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
189511000
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
286031000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4621000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4608000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2411000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1819000
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
7032000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
6427000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
876000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
417000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-349000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-141000
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
527000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
276000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7559000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6703000
CY2022Q4 bprn Allowance For Loan Losses
AllowanceForLoanLosses
-4638000
CY2021Q4 bprn Allowance For Loan Losses
AllowanceForLoanLosses
-4332000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
374000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
421000
CY2021Q4 bprn Deferred Tax Asset Organization Costs
DeferredTaxAssetOrganizationCosts
5000
CY2022Q4 bprn Deferred Tax Assets Branch Acquisition
DeferredTaxAssetsBranchAcquisition
26000
CY2021Q4 bprn Deferred Tax Assets Branch Acquisition
DeferredTaxAssetsBranchAcquisition
27000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
681000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
400000
CY2022Q4 bprn Deferred Tax Assets Core Deposit Intangible
DeferredTaxAssetsCoreDepositIntangible
397000
CY2021Q4 bprn Deferred Tax Assets Core Deposit Intangible
DeferredTaxAssetsCoreDepositIntangible
293000
CY2022Q4 bprn Deferred Tax Assets Deferred Ppp Loans
DeferredTaxAssetsDeferredPPPLoans
28000
CY2021Q4 bprn Deferred Tax Assets Deferred Ppp Loans
DeferredTaxAssetsDeferredPPPLoans
726000
CY2022Q4 bprn Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
4726000
CY2021Q4 bprn Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
4446000
CY2022Q4 bprn Deferred Tax Assets Serp Liabiltiy
DeferredTaxAssetsSERPLiabiltiy
202000
CY2021Q4 bprn Deferred Tax Assets Serp Liabiltiy
DeferredTaxAssetsSERPLiabiltiy
89000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
3322000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14394000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10739000
CY2022Q4 bprn Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
1341000
CY2021Q4 bprn Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
993000
CY2022Q4 bprn Deferred Tax Liabilities Deferred Loan Costs
DeferredTaxLiabilitiesDeferredLoanCosts
335000
CY2021Q4 bprn Deferred Tax Liabilities Deferred Loan Costs
DeferredTaxLiabilitiesDeferredLoanCosts
242000
CY2022Q4 bprn Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
4515000
CY2021Q4 bprn Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
4277000
CY2022Q4 bprn Deferred Tax Liabilities Acquisition Accounting Adjustments
DeferredTaxLiabilitiesAcquisitionAccountingAdjustments
8000
CY2021Q4 bprn Deferred Tax Liabilities Acquisition Accounting Adjustments
DeferredTaxLiabilitiesAcquisitionAccountingAdjustments
7000
CY2022Q4 bprn Deferred Tax Liabilities Goodwill Amortization
DeferredTaxLiabilitiesGoodwillAmortization
596000
CY2021Q4 bprn Deferred Tax Liabilities Goodwill Amortization
DeferredTaxLiabilitiesGoodwillAmortization
397000
CY2021Q4 bprn Deferred Tax Liabilities Section481a Adj
DeferredTaxLiabilitiesSection481aAdj
18000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
291000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6795000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6225000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7599000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4514000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7151000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6130000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1629000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1326000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.045
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
772000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.023
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
790000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.027
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-146000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.004
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
17000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.001
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
17000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.001
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
8000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0
CY2022 bprn Income Tax Reconciliation Internal Revenue Service Refund
IncomeTaxReconciliationInternalRevenueServiceRefund
-516000
CY2022 bprn Effectiveincometaxratenternal Revenue Service Refund
EffectiveincometaxratenternalRevenueServiceRefund
-1.5
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
196000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.005
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
12000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7559000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6703000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1800000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2000000
CY2022Q4 bprn Operatinglosscarryforwardslimitations
Operatinglosscarryforwardslimitations
222000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
CY2022Q4 bprn Gross Carrying Amount Operating Lease Right Of Use Asset
GrossCarryingAmountOperatingLeaseRightOfUseAsset
17919000
CY2021Q4 bprn Gross Carrying Amount Operating Lease Right Of Use Asset
GrossCarryingAmountOperatingLeaseRightOfUseAsset
18408000
CY2021Q4 bprn New Lease Operating Lease Right Of Use Asset
NewLeaseOperatingLeaseRightOfUseAsset
1504000
CY2022Q4 bprn Accumulated Amortization Operating Lease Right Of Use Asset
AccumulatedAmortizationOperatingLeaseRightOfUseAsset
1893000
CY2021Q4 bprn Accumulated Amortization Operating Lease Right Of Use Asset
AccumulatedAmortizationOperatingLeaseRightOfUseAsset
1998000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16026000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17914000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16772000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18561000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0254
CY2019Q2 bprn Branch Deposits
BranchDeposits
177900000
CY2019Q2 bprn Branch Deposits Net Cash
BranchDepositsNetCash
159900000
CY2022Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
627000
CY2022Q4 us-gaap Goodwill
Goodwill
8900000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2700000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2940000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
94000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
97000
CY2022 us-gaap Lease Cost
LeaseCost
2794000
CY2021 us-gaap Lease Cost
LeaseCost
3037000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
2309000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2488000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2298000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2065000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2048000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1854000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1559000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10371000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20195000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3423000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16772000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2700000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2900000
CY2022 bprn Base Rental Payments
BaseRentalPayments
305000000
CY2021 bprn Base Rental Payments
BaseRentalPayments
305000000
CY2022Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
8900000
CY2022 bprn Goodwill Amortization Period
GoodwillAmortizationPeriod
P15Y
CY2021Q4 us-gaap Goodwill
Goodwill
8853000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2393000
CY2022 bprn Amortization Expense
AmortizationExpense
-568000
CY2022Q4 us-gaap Goodwill
Goodwill
8853000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1825000
CY2020Q4 us-gaap Goodwill
Goodwill
8853000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3036000
CY2021 bprn Amortization Expense
AmortizationExpense
-643000
CY2021Q4 us-gaap Goodwill
Goodwill
8853000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2393000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
492000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
415000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
338000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
261000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
183000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
136000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1825000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
53351000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
83402000
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
201000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1353907000
CY2022Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
1742000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4756000
CY2022Q4 us-gaap Deposits
Deposits
1347730000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
10000000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1027000
CY2021Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
158716000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
101158000
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
208000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1318543000
CY2021Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
1345000
CY2021Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4218000
CY2021Q4 us-gaap Deposits
Deposits
1446143000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1044000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
407650
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.08
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
76900
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.18
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
100
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.75
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
330650
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.45
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M13D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3463695000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
330650
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.45
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M13D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3463695000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
431980
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.73
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22480
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.22
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1350
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
25.49
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
500
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
407650
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.08
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M10D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4069054000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
395125
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.68
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M8D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4069054000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
685000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M26D
CY2022Q4 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Capital Adequacy Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioCapitalAdequacyMinimum
0.045
CY2022Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.03
CY2022Q4 us-gaap Banking Regulation Leverage Buffer Minimum
BankingRegulationLeverageBufferMinimum
0.04
CY2022Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.06
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2022Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.08
CY2022Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.10
CY2022Q4 us-gaap Banking Regulation Capital Conservation Buffer Capital Conserved Minimum
BankingRegulationCapitalConservationBufferCapitalConservedMinimum
0.025
CY2022Q4 us-gaap Capital
Capital
233657000
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.15309
CY2022Q4 us-gaap Excess Capital
ExcessCapital
160256000
CY2022Q4 us-gaap Banking Regulation Capital Conservation Buffer Total Risk Based Capital Actual
BankingRegulationCapitalConservationBufferTotalRiskBasedCapitalActual
0.105
CY2022Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
152625000
CY2022Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.10
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
217196000
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.14231
CY2022Q4 us-gaap Excess Tier One Risk Based Capital
ExcessTierOneRiskBasedCapital
129731000
CY2022Q4 us-gaap Banking Regulation Capital Conservation Buffer Tier One Risk Based Capital Actual
BankingRegulationCapitalConservationBufferTierOneRiskBasedCapitalActual
0.085
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
122100000
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2022Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
217196000
CY2022Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.14231
CY2022Q4 bprn Excess Common Equity Tier One Capital
ExcessCommonEquityTierOneCapital
106838000
CY2022Q4 us-gaap Banking Regulation Capital Conservation Buffer Common Equity Tier One Risk Based Capital Actual
BankingRegulationCapitalConservationBufferCommonEquityTierOneRiskBasedCapitalActual
0.07
CY2022Q4 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
99206000
CY2022Q4 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Well Capitalized Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioWellCapitalizedMinimum
0.065
CY2022Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
217196000
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.13474
CY2022Q4 us-gaap Excess Tier One Leverage Capital
ExcessTierOneLeverageCapital
104775000
CY2022Q4 us-gaap Banking Regulation Leverage Buffer Actual
BankingRegulationLeverageBufferActual
0.065
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
80596000
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.05
CY2021Q4 us-gaap Capital
Capital
221113000
CY2021Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.15085
CY2021Q4 us-gaap Excess Capital
ExcessCapital
153906000
CY2021Q4 us-gaap Banking Regulation Capital Conservation Buffer Total Risk Based Capital Actual
BankingRegulationCapitalConservationBufferTotalRiskBasedCapitalActual
0.105
CY2021Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
146577000
CY2021Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.10
CY2021Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
204493000
CY2021Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.13951
CY2021Q4 us-gaap Excess Tier One Risk Based Capital
ExcessTierOneRiskBasedCapital
124591000
CY2021Q4 us-gaap Banking Regulation Capital Conservation Buffer Tier One Risk Based Capital Actual
BankingRegulationCapitalConservationBufferTierOneRiskBasedCapitalActual
0.085
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
117262000
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2021Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
204493000
CY2021Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.13951
CY2021Q4 bprn Excess Common Equity Tier One Capital
ExcessCommonEquityTierOneCapital
102604000
CY2021Q4 us-gaap Banking Regulation Capital Conservation Buffer Common Equity Tier One Risk Based Capital Actual
BankingRegulationCapitalConservationBufferCommonEquityTierOneRiskBasedCapitalActual
0.07
CY2021Q4 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
95275000
CY2021Q4 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Well Capitalized Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioWellCapitalizedMinimum
0.065
CY2021Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
204493000
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.12062
CY2021Q4 us-gaap Excess Tier One Leverage Capital
ExcessTierOneLeverageCapital
110193000
CY2021Q4 us-gaap Banking Regulation Leverage Buffer Actual
BankingRegulationLeverageBufferActual
0.065
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
84764000
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.05
CY2022 dei Auditor Name
AuditorName
Wolf and Company, P.C.
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022 dei Auditor Firm
AuditorFirmId
392

Files In Submission

Name View Source Status
0001193125-23-079231-index-headers.html Edgar Link pending
0001193125-23-079231-index.html Edgar Link pending
0001193125-23-079231.txt Edgar Link pending
0001193125-23-079231-xbrl.zip Edgar Link pending
bprn-20221231.xsd Edgar Link pending
d459130d10k.htm Edgar Link pending
d459130dex211.htm Edgar Link pending
d459130dex311.htm Edgar Link pending
d459130dex312.htm Edgar Link pending
d459130dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g459130page36a.jpg Edgar Link pending
g459130page49a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
bprn-20221231_def.xml Edgar Link unprocessable
bprn-20221231_lab.xml Edgar Link unprocessable
bprn-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d459130d10k_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bprn-20221231_cal.xml Edgar Link unprocessable